NDC 82804-005 – Acyclovir

Acyclovir 400 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC82804-005

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Proficient Rx LP
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA210401
Marketed since
June 20, 2023
Listing expires
December 31, 2026
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (8)

Package NDCDescriptionSince
82804-005-066 TABLET in 1 BOTTLE (82804-005-06)Jan 9, 2024
82804-005-1515 TABLET in 1 BOTTLE (82804-005-15)Jan 9, 2024
82804-005-2020 TABLET in 1 BOTTLE (82804-005-20)Jan 9, 2024
82804-005-2121 TABLET in 1 BOTTLE (82804-005-21)Jan 9, 2024
82804-005-3030 TABLET in 1 BOTTLE (82804-005-30)Aug 31, 2023
82804-005-3535 TABLET in 1 BOTTLE (82804-005-35)Jan 9, 2024
82804-005-6060 TABLET in 1 BOTTLE (82804-005-60)Aug 31, 2023
82804-005-9090 TABLET in 1 BOTTLE (82804-005-90)Aug 31, 2023

Other Acyclovir products